Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Histopathology. 2020 Sep 14;78(2):252–264. doi: 10.1111/his.14211

Table 3.

Cause-specific analysis of recurrence-free survival

Univariate analysis Multivariate analysis
P HR (95% CI) P
Age 0.0979 1.029 (1.009 – 1.049) 0.0045
Gender 0.2260
History of prior malignancy 0.0365
Tumour grade 0.7892
Tumour location 0.9962
Tumour budding 0.0006
Intra-epithelial tumour-infiltrating lymphocytes 0.0068 0.0348
 Yes 1
 No 1.862 (1.045–3.316)
Desmoplastic reaction < 0.0001 < 0.0001
 Immature/myxoid 3.382 (1.861–3.316)
 Intermediate 0.888 (0.461–1.712)
 Mature 1
Lymphovascular invasion < 0.0001
Perineural invasion 0.0036
Tumour deposits < 0.0001
MMR expression 0.8230
pT stage < 0.0001
pN stage < 0.0001
pTNM prognostic group < 0.0001 < 0.0001
 I 0.159 (0.055–0.457)
 II 0.355 (0.203–0.620)
 III 1

HR, hazard ratio; CI, confidence interval; pT, pathological T category; pTNM, pathological tumour–node–metastasis; MMR, mismatch repair protein.

Bold indicates statistical significance.